Transcript Embase
Embase
Find quick, relevant answers to your biomedical questions
Section 1.
Review / Confirm understanding of your research needs
Section 1.
Your challenges & Research Needs
• Conduct systematic reviews of the literature • Set up complex search strategies and alerts for stakeholders and departments • Search Medline and Embase together • Set up and distribute alerts relating to evidence-based medicine • Access the most up to date information related to a disease that you are tracking • Make sure that all relevant information is disseminated throughout the organization • Monitor and track all adverse events for early and complete detection of any and all adverse effects (signaling) • Make sure you respond to your internal stakeholder’s request in a timely manner
Section 2.
Evidence Based Medicine / Systematic Searching
Section 2. “
How do you know if one treatment will work better than another, or if it will do more harm than good?
” Cochrane Reviews are systematic reviews of primary research in human health care and health policy, and are internationally recognized as the highest standard in evidence-based health care . They investigate the effects of interventions for prevention, treatment and rehabilitation. They also assess the accuracy of a diagnostic test for a given condition in a specific patient group and setting. They are published online in
The Cochrane Library
.
Section 2. “
How do you know if one treatment will work better than another, or if it will do more harm than good?
” Each systematic review addresses a clearly formulated question. For example:
Can antibiotics help in alleviating the symptoms of a sore throat?
All the existing primary research on a topic that meets certain criteria is searched for and collated, and then assessed using stringent guidelines, to establish whether or not there is conclusive evidence about a specific treatment. The reviews are updated regularly, ensuring that treatment decisions can be based on the most up-to-date and reliable evidence.
Section 2.
Case Study: Embase & Evidence Based Medicine
A real example of the high risks of NOT using Embase
Section 2.
Medicine Without Evidence
Johns Hopkins’ Tragedy:
Could Librarians Have Prevented a Death?
Source: http://newsbreaks.infotoday.com/nbreader.asp?ArticleID=17534
Section 2.
Section 2.
Section 2.
EBM Terms in Embase / Emtree
via Advanced Limits in Advanced Search via Emtree
Section 3.
What is Embase and How it Supports Academic Institutions
Section 3.
What is Embase?
Embase is the world ’ s most comprehensive, intelligent biomedical research tool, providing the drug and drug-related research community with reliable and authoritative content, to advance new biomedical and pharmaceutical discovery.
Confidence
Find all relevant articles that may not otherwise be found by alternative databases
Deep Biomedical Indexing
All relevant, up-to-date, biomedical information from the research literature
Precise Retrieval
Deep and focused research through powerful retrieval tools
Section 3.
How Embase Delivers Value…
...by including literature and information resources in a timely manner ...by reading full-text to identify
drugs, diseases, adverse affects,
clinical trials, drug trade names etc. ...
by enabling advanced search filters to drill down a comprehensive search to a relevant and manageable record set Conference proceedings Scientific Journals In Press (unpublished)
Deep indexing using own taxonomy (EMTREE) Very powerful Search Environment
...by allowing users to automate searching and result management
We make sure you don’t miss any biomedical literature They only close alternative is reading all the articles Good precision and recall balance Automation and documentation
Section 3.1
Content
Section 3.1
Content Overview
Emtree:
Biomedical thesaurus, over 60k terms
Embase:
Fully indexed: Over 7,700 journals (including MEDLINE), 1950-
MEDLINE:
2,500 journals unique to Embase, mapped to Embase indexing, 1950- (including MEDLINE Classic)
Embase Classic:
Digitally scanned and re-indexed, 1947-1973
AIP and In Process:
Indexing added, from 2009
Conference Abstracts:
Indexing added, from 2009 2009 1947 1950 And counting … 2,700 records added per day 1,000,000 records added per year 1974
Section 3.1
Embase Scope & Coverage (2012)
Pharmacology & Taxicology 12% General Clinical Medicine 11% Genetics, Biochemistry & Molecular Biology 10% Neurology & Behavioral Medicine 8% Microbiology & Infectious Disease 7% Cardiology & Hematology 6% Psychiatry & Mental Health 6% Oncology 5% Healthcare Policy & Management 4% Allergy & Immunology 4% Pediatrics 4% Endocrinology & Metabolism 3% Obstetrics & Gynecology 3% Biomedical Engineering & Medical Devices 3% Anesthesiology & Intensive Care 3% Gastroenterology 2% Respiratory Medicine 2% Nephrology & Urology 2% Dermatology 2%
Other topics 28%
Including public health, basic biomedical science and topics included from MEDLINE
Section 3.1
Embase vs MEDLINE – Scope
Similar overall pattern of coverage
... but with two major differences
1. Pharmacology & toxicology
Embase: 11.2% (889 titles) MEDLINE: 8.3% (465 titles)
2. General clinical medicine
Embase: 10.5% (835 titles) MEDLINE: 8.9% (495 titles)
Section 3.1
Embase vs MEDLINE – Searching the Difference
Section 3.1
Embase Records
Section 3.1
1.0 m 800 K 600 K 400 K 200 K
Embase Records Medline on PubMed
01 02 03 04 05 06 07 08 09 10 11
Section 3.1
Embase (Active) Journals in 2012
Embase:
now covers 7960 journals (20 March 2012) Indexed at Embase (5396 titles) Indexed by MEDLINE (e.g on PubMed) (5592 titles)
2368 journals
Indexed at Embase Unique to Embase
Search:
[embase]/lim
3028 journals
Indexed at Embase Also covered by MEDLINE
Search:
[embase]/lim AND [medline]/lim
2564 journals
Indexed by MEDLINE Also in MEDLINE
Search:
[medline]/lim NOT [embase]/lim
Section 3.1
1.0 m 800 K 600 K 400 K 200 K
Journal Articles Conference Abstracts
01 02 03 04 05 06 07 08 09 10 11
Section 3.2
Indexing (Emtree Thesaurus)
Section 3.2
Deep Indexing – EMTREE
Emtree is a Life Science Thesaurus. A controlled vocabulary for Biomedicine and related Life Sciences
Easy to Search
Over 60,000 preferred terms and more than 270,000 synonyms
Comprehensive Drug Searching
Chemical names, trade names, laboratory/research codes, and more than 28,000 generic drugs and chemicals (FDA, EMEA and WHO)
Up-To-Date
The latest drugs, diseases, organisms and procedures are indexed and added annually
Inclusive Terminology
All MeSH terms, with links to more than 20,000 CAS registry number
Section 3.2
Deep Indexing – EMTREE
60K terms (>260,000 synonyms) and all MeSH terms 29K drug and chemical terms Emtree updated 3 times a year (back-posting each time) All drug generic names described by FDA and EMA, all International Non-Proprietary Names (INNs) described by WHO from 2000.
What is mapping?
Mapping means that searchers get the same results regardless of which term they use, e.g. Vioxx (synonym) or rofecoxib (the preferred term).
Section 3.2
Deep Indexing – EMTREE
Database Thesaurus
Embase Emtree
Search
'monoclonal antibody'/exp/dd_dt AND 'breast cancer'/exp/dm_dt AND [2009-2010]/py
[Note: dt = drug therapy]
PubMed MeSH "Antibodies,Monoclonal /therapeutic use“[Mesh] AND "Breast Neoplasms/drug therapy"[Mesh] Limits: Publication Date from 2009 to 2010 Embase vs. PubMed : in-depth indexing + Emtree tree structure
Result
2075 357
Section 3.2
Embase vs PubMed
2 thesaurus assisted searches but different results!
Section 3.2
Embase vs PubMed
This article, although present in Medline, is not indexed with ‘digoxin’ and therefore our search for ‘digoxin’ and ‘antibacterial agents’ did not find this article – it’s found in Embase.
Section 3.2
Embase vs MEDLINE – Randomized Controlled Trails
Language
Turkish Korean Portuguese Dutch Chinese Polish Spanish French German
Embase on Elsevier
613 134 712 606 5366 491 2316 3952 8393
Medline on Ovid
75 46 442 442 3945 434 2137 3904 8566
Embase Advantage 538 88 270 164 1421 57 179 48 -173 Percent 717% 191% 61% 37% 36% 13% 8% 1% -2%
Section 3.2
Embase vs MEDLINE – Searching for Drugs
Product Name 2
Liptor Advair Plavix Nexium Norvasc Enbrel Zyprexa Remicade Diovan Risperdal
Search Term Emtree Preferred Term
Atrovastatin Fluticasone propionate plus Salmeterol Clopidogrel Esomeprazole Amlodipine besylate Etanercept Olanzapine Infliximab Valsartan Risperidone
MeSH Preferred Term or Substance Name 3
Atrovastatin 3 Fluticasone propionate plus Salmeterol 3 Clopidogrel 3 Omeprazole 4 Amlodipine 4 TNFR-Fc fusion protein 4 Olanzapine 3 Infliximab 3 Valsartan 3 Risperidone
Citations Embase
7,668 839
Medline
1,654 39 9,552 1,493 439 5,197 7,775 8,223 2,725 7,991 1,613 1,558 621 1,375 1,498 2,461 508 1,488